Novo Nordisk got a once-daily hemophilia injection cleared days before 2025. Nov...
Roche’s 2019 acquisition of Philadelphia-based gene therapy specialist Spark The...
Danish pharmaceutical company Novo Nordisk has received approval from the Europe...
Danish pharmaceutical giant Novo Nordisk announced plans to invest 8.5 billion D...
After Amylyx and PTC, Corcept has also decided to withdraw from the amyotrophic ...
The Food and Drug Administration (FDA) has uncovered additional safety concerns ...
Ro, a direct-to-consumer health and wellness company, has announced a partnershi...
Carisma, a Philadelphia-based biotech company, is undergoing significant restruc...
BioAge Labs, a recent success in the biotechnology IPO market, has made a surpri...
As part of a first-line treatment for patients with inoperable pancreatic adenoc...
Novartis has paid out $1 billion upfront for worldwide rights to PTC Therapeutic...
Likely to be effective next year, GE HealthCare will assume full control of Niho...
A new independent survey of senior US pharma regulatory professionals suggests t...
Merck has released that its drug, Winrevair, reduced the risk of death in patien...
A late-stage study testing the efficacy of Biohaven’s taldefgrobep alpha against...
A bispecific antibody has emerged in the HER2 arena, exhibiting a different prof...
